Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Moderna’s Covid-19 vaccine SPIKEVAX receives full FDA approval

Moderna, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to...

Russia’s Petrovax ready to produce inhalable version of the Convidecia coronavirus vaccine

The launch of the project for the production of the inhalable version of the vaccine will depend on the registration of the injectable form...

Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for...

U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib)

AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...

Expo 2020 in Dubai: Russian pharma industry adapts to pandemic, open to cooperation with Arab world

The 13th meeting of the Russian-Arab Business Council session was held on 25-26 January. Russia's pharmaceutical industry has managed not only to adapt to the...

Argentina displays interest in nasal form of Russia’s Sputnik V vaccine

Argentina has displayed an interest in the nasal form of Russia's Sputnik V coronavirus vaccine and other Russian developments for treating and preventing COVID-19,...
spot_img

Expert Articles

spot_img